Company Monitoring Page for Keryx

latest headlines for company on cafepharma

Keryx Biopharma gets U.S. approval for kidney drug
Yahoo/Reuters
Fri, 09/5/14 - 11:58 am
Tags:
FDA, Keryx, Zerenex, chronic kidney disease
September Biotech Calendar
TheStreet.com
Tue, 08/26/14 - 10:08 am
Tags:
Keryx, Orexigen, AstraZeneca, Nektar, Salix, Alimera, Amarin, Merck, EXACT Sciences, NPS Pharmaceuticals
Keryx touts its kidney drug with an FDA decision around the corner
Fierce Biotech
Fri, 07/25/14 - 11:14 am
Tags:
Keryx, FDA, hyperphosphatemia, kidney dialysis, Zerenex
Keryx Biopharma: Approval Delay Does Not Change Zerenex Prospects Or Differentiation
Seeking Alpha
Fri, 05/30/14 - 12:28 pm
Tags:
Keryx, Zerenex
Keryx announces FDA extends PDUFA date for Zerenex
The Fly on the Wall
Fri, 05/23/14 - 07:05 am
Tags:
FDA, Zerenex, Keryx
Zerenex For The Treatment Of Hyperphosphatemia: A New Use For An Old Compound
Seeking Alpha
Tue, 02/25/14 - 10:59 am
Tags:
hyperphosphatemia, Zerenex, Keryx
4 Biotech Stocks Making Big Moves
Wall St Cheat Sheet
Fri, 01/17/14 - 05:31 pm
Tags:
Halozyme, Pacific Biosciences, Keryx, Intercept Pharma
Oppenheimer Sees Five Biotech Stocks to Buy With Potential 50% Upside, or More
24/7 Wall St
Tue, 01/7/14 - 11:47 am
Tags:
Celldex Therapeutics, Immunomedics, Keryx, Merrimack Pharmaceuticals, Protalix BioTherapeutics
22 Biotech Stock Predictions for 2014
TheStreet.com
Mon, 01/6/14 - 09:47 am
Tags:
biotech, Vertex Pharmaceuticals, Orexigen, Retrophin, Valeant Pharmaceuticals, Questcor, Biomarin, Merck, NeoStem, Amgen, Gilead Sciences, Vanda, Keryx, Peregrine Pharmaceuticals, CelSci, Regeneron, Cempra, Dendreon, Clovis Oncology, Halozyme, NPS Pharmaceuticals
Understanding Zerenex's Patent Protection And Latest Issuance
Seeking Alpha
Tue, 12/31/13 - 10:13 am
Tags:
Zerenex, patents, Keryx
The Future Is Bright: Keryx Biopharmaceuticals Receives Patent Protection
Wall St Cheat Sheet
Thu, 12/19/13 - 11:34 am
Tags:
Keryx, patents, Zerenex
3 Bold Predictions for Keryx Biopharmaceuticals in 2014
Motley Fool
Mon, 12/16/13 - 08:13 am
Tags:
Keryx, chronic kidney disease, Zerenex
3 Drugmakers to Watch in the New Year
Motley Fool
Wed, 12/11/13 - 11:10 am
Tags:
pimavanserin, Acadia, Zerenex, Keryx, Iclusig, Ariad Pharmaceuticals
Keep a Close Watch on Geron, Keryx, and Sangamo Today
Motley Fool
Fri, 12/6/13 - 10:21 am
Tags:
Geron, Keryx, Sangamo BioSciences
2014 FDA Drug Approval Decision Calendar
TheStreet.com
Wed, 11/27/13 - 08:39 am
Tags:
FDA, drug approvals, GSK, Gilead, Theravance, Auxilium, Amarin, Bristol-Myers Squibb, Biogen Idec, Pozen, Vanda, Chelsea Therapeutics, pSivida, Alimera, United Therapeutics, Biomarin, JNJ, Pharmacyclics, Celgene, MannKind, Santarus, AstraZeneca, Durata Therapeutics, Eli Lilly, Omeros, BioDelivery Sciences, Anacor, Keryx, Cubist Pharmaceuticals, Nektar
Zerenex- The New Spark For Keryx?
Seeking Alpha
Mon, 11/25/13 - 10:57 am
Tags:
Zerenex, Keryx, Sanofi, OPKO Health
Why Doctors, Dialysis Providers And Investors Are Excited About Zerenex
Seeking Alpha
Mon, 11/11/13 - 11:39 am
Tags:
dialysis, Zerenex, Keryx
This Week in Biotech
Motley Fool
Sun, 11/10/13 - 12:56 pm
Tags:
Keryx, Geron, Arena, Eisai, Vivus, Curis, Immunogen
Keryx's kidney drug meets main goals of mid-stage study
Yahoo/Reuters
Tue, 11/5/13 - 09:56 am
Tags:
Keryx, Zerenex, chronic kidney disease
3 Things You Need to Know from Keryx's Stifel Conference Presentation
Motley Fool
Sat, 09/14/13 - 11:02 am
Tags:
Keryx, chronic kidney disease, dialysis, hyperphosphatemia, Zerenex

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.